// App-Quantinova.ai

: Novel 17-Plex Flow Cytometry Assay for Comprehensive Immunophenotyping and Characterization of Plasma Cells (PC) in Relapsed/Refractory (RR) Multiple Myeloma (MM) Patients

Researchers

Presenter

  • Iva Lelios

Principal Investigators

  • Enrique Gomez

  • Iryna Dekhtiarenko

  • Priscila Camillo Teixeira

  • Ann-Marie E Bröske

Medical Centers

  • Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland

  • Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany

Locations

  • Switzerland

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Cluster of Differentiation 19

  • Cluster of differentiation 45

  • Cluster of Differentiation 38

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase

  • Cluster of Differentiation 56

  • Programmed death-ligand 1

  • Syndecan-1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

  • Global

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A